Anticoagulant Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 1
Phase I Study of MT1011 Injection in Healthy Subjects
Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd.40 enrolled1 locationNCT07024160
Recruiting
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting
Phase 4
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414
Recruiting
Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Venous ThromboembolismPulmonary EmbolismAnticoagulant-induced Bleeding
Peking Union Medical College Hospital300 enrolled1 locationNCT06194617